Loading...
NPI 1902059538 · Portland, OR · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Legacy Laboratory Services, LLC is a clinical medical laboratory provider located in Portland, Oregon. This profile covers 295 Medicare and 283 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Legacy Laboratory Services, LLC |
| Address | 1225 Ne 2nd Ave |
| City | Portland |
| State | OR |
| ZIP | 97232 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | October 28, 2008 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $24.8M |
| Medicare | $2.8M |
Provider is strongly Medicaid-focused: reported lifetime Medicaid revenue is $24.8M versus $2.8M in Medicare, making Medicaid the dominant payer by scale for this lab. This payer mix implies contracting and operational emphasis on state Medicaid programs rather than Medicare fee-for-service as the primary revenue source.
Revenue concentration is meaningful but not extreme: the top three Medicare codes account for 34.7% of Medicare revenue and the top three Medicaid codes account for 33.9% of Medicaid revenue. This indicates a moderately concentrated revenue base where a handful of panels and high-volume tests materially move payer-level revenue.
Service-line profile shows a broad clinical laboratory footprint centered on routine chemistry and hematology plus population testing: Medicare top codes include 80053, 36415, and 80061 (CMP, venipuncture, lipid panel), while Medicaid volume is dominated by high-throughput NAAT and infectious disease testing such as U0003, 87491, and 87591. The mix of routine panels (e.g., 80053, 80061, 85025, 84443) and large volumes of STI/COVID NAATs suggests an operation combining outpatient phlebotomy and centralized molecular testing.
Medicaid competitive standing is pronounced in-state for several test lines: codes such as 87491 and 87591 are listed as an "extreme outlier, far above typical state volume" (each 59.3K claims and $1.5M revenue), 80053 and 84443 rank #2 in-state with "extreme outlier" volumes (153.4K claims for 80053), and 87660 ranks #1 in-state as an "extreme outlier." These labels and ranks indicate the provider is a major statewide player for NAAT-based STI testing and high-volume chemistry panels.
Drug testing is a material product line across payers: Medicaid shows high volume for presumptive drug testing 80307 (55.4K claims, $2.1M revenue; ranks #3 in-state, "notably above typical state volume") and definitive testing G0480 also appears prominently on Medicaid and Medicare (Medicaid G0480: 21.8K claims, $1.2M revenue; Medicare G0480: 755 claims, $77K revenue). The presence of both 80307 and G0480 across payers signals capacity for both screening and confirmatory toxicology workflows.
Medicare footprint is nationally visible but described as typical for many routine codes: several high-revenue Medicare codes (80053, 80061, 84443, 85025) rank in the top national percentiles (many at the 99–100th percentile) yet are annotated as "typical, unremarkable volume" in the national context, while 36415 is noted as "notably above typical national volume." In sum, the provider participates at scale nationally for routine lab codes but is not universally an outlier on Medicare except for venipuncture volume.
Operational throughput is evidenced by very large claim counts on Medicaid that imply centralized specimen handling: examples include 153.4K claims for 80053, 153K claims for 85025, and 214.9K claims for 36415 on Medicaid. Those claim totals, alongside high-volume NAAT counts (U0003 with 40.6K claims and U0005 with 29.2K claims), support a conclusion of high-volume processing and broad specimen intake across sites or collection partners.
The provider has longstanding enrollment: NPI enumerated 2008-10-28 (~18 years ago), indicating sustained presence in Medicare/Medicaid billing. Combined with the state-level outlier status on multiple Medicaid codes, this longevity supports that the billing patterns reflect an established operational focus rather than a short-term or newly scaled testing arrangement.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
295 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 24,900 | $10 | $249K |
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 34,010 | $10 | $238.1K |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 16,010 | $10 | $208.1K |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 12,250 | $20 | $196K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 19,500 | $10 | $156K |
| 83036 | Sugar in the bloodstream can get attached to the hemoglobin in red blood cells. Once the sugar is attached, it stays there for the lifetime of the red blood cell (around 120 days or over 3 months).… | 9,450 | $10 | $94.5K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 760 | $100 | $77K |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 2,390 | $30 | $69.3K |
| 83970 | Parathyroid hormone test measures the level of PTH in the blood. This test is done to ascertain the level of calcium and evaluate the parathyroid function. | 1,720 | $40 | $69K |
| 82607 | The lab analyst performs a test to measure the amount of vitamin B12 in a patient specimen, typically in patient blood. | 4,460 | $20 | $66.9K |
Showing 1–10 of 295
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 295 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
283 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 40,580 | $60 | $2.5M |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 55,410 | $40 | $2.1M |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 59,300 | $30 | $1.5M |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 59,260 | $30 | $1.5M |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 21,750 | $60 | $1.2M |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 153,370 | $10 | $920.2K |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 86,140 | $10 | $861.4K |
| 87389 | The lab analyst performs a test to screen for human immunodeficiency virus, called HIV. The test screens for antigens of the HIV 1 virus and antibodies to the HIV 1 and HIV 2 viruses using an… | 39,430 | $20 | $630.8K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 152,950 | $1 | $611.8K |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 84,740 | $10 | $593.2K |
Showing 1–10 of 283
How this provider's Medicaid billing volume and revenue compare to other Oregon providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Oregon median
283 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 4 | 60 | 420 | $60 | $405.1K |
| 80050 | The lab analyst performs testing for the specific group of clinical laboratory procedures in the general health panel. Payers typically consider 80050 to apply only when the clinician orders the… | 2 | 20 | 780 | $30 | $360.1K |
| 81229 | The lab analyst performs the technical lab test using comparative genomic hybridization (CGH) microarray, also referred to as chromosomal microarray (CMA) or molecular karyotype performed by… | 2 | 10 | 970 | $370 | $357.9K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 5 | 60 | 460 | $40 | $327.4K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 3 | 80 | 1,210 | $40 | $294.3K |
| 86481 | The lab analyst performs a test to evaluate an antigen response to certain tuberculosis (TB) antibodies by enumerating T cells that produce gamma interferon. | 3 | 10 | 3,160 | $60 | $292.3K |
| 86003 | The lab analyst performs the technical lab test to analyze a specimen such as serum for allergen–specific immunoglobulin E (IgE), using a crude allergen extract. The test result is quantitative or… | 3 | 10 | 390 | $120 | $240.6K |
| 88175 | The lab analyst performs the technical lab test to analyze a cervical or vaginal cytopathology specimen that a clinician collected in preservative fluid. The test uses automated thin layer… | 9 | 20 | 2,750 | $20 | $205.7K |
| H0048 | Alcohol and/or other drug testing: collection and handling only, specimens other than blood | 29 | 160 | 2,750 | $20 | $205.1K |
| 83013 | The lab analyst tests multiple breath samples for the presence of an isotope that indicates the presence of the H. pylori bacteria. This organism can cause irritation and ulcers of the stomach lining. | 3 | 10 | 2,530 | $50 | $203.4K |
Showing 1–10 of 283
Other providers in the same ZIP code as Legacy Laboratory Services, LLC, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.